ResMed Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | $765.3M | $3.36B | $273.7M |
| FY2023 | $1.43B | $4.13B | $227.9M |
| FY2024 | $697.3M | $4.86B | $238.4M |
| FY2025 | $658.4M | $5.97B | $1.21B |
| FY2026 | $399.4M | $6.59B | $1.47B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | $765.3M | $3.36B | $273.7M |
| FY2023 | $1.43B | $4.13B | $227.9M |
| FY2024 | $697.3M | $4.86B | $238.4M |
| FY2025 | $658.4M | $5.97B | $1.21B |
| FY2026 | $399.4M | $6.59B | $1.47B |